BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Leukemia

1. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. EPS15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. ZRSR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. DDX10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. GMPS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. RAP1GDS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. CNTRL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. MLLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. PCM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. RPN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. HIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. BCORL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. MYH9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. FSTL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. KAT6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. RANBP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. TAL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. ZNF384
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. TTL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. ZNF521
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. CBLB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. GAS7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. HSP90AB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. IKBKB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. CBLC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. CRTC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. FCRL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. HOXC11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. LRP1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. NFKBIE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. PTPRT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. DCTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. GPHN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. HOXD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. KTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. NACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. PRRX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. PSIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. RABEP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. BCL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. PREX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. PTPRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. PTPRK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. RPL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. SDC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. TCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. TFPT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. WHSC1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. CHCHD7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. CNOT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. COX6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. ECT2L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. FAM46C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. FNBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. IL21R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. LSM14A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. MDS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. RBM10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. RNF213
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. RSPO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. SMARCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. SRGAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. ZFHX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. ZNF278
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. BCL7A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. C12orf9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. C15orf65
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. C2orf44
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. CCNB1IP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. CEP89
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. CLTCL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. FAM131B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. FBXO11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. H3F3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. HIST1H4I
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. HMGN2P46
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. HOOK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. KDSR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. KIAA1598
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. LHFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. MAP3K13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. MYO5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. PAFAH1B2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. PDE4DIP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. PWWP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. RMI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. RNF217-AS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. RSPO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. RUNDC2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. SS18L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. TCEA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. TPM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. TRAF7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. VTI1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. ZCCHC8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. Cytokeratin fragment 21-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. MAP-Tau mRNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MK167
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CAD-ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]